The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of survival outcomes with progression heterogeneity in patients (pts) treated with pembrolizumab (pembro).
 
Lawrence H. Schwartz
Consulting or Advisory Role - Novartis
Research Funding - Lilly; Merck
 
Seth Robey
Employment - Merck
Stock and Other Ownership Interests - Amgen; ION Pharma
 
David C. Turner
Employment - Merck
 
Yiwei Zhang
Employment - Merck
 
Eunhee Kim
Employment - Merck
 
Dinesh de Alwis
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Robin Mogg
Employment - Merck
Stock and Other Ownership Interests - Merck
Patents, Royalties, Other Intellectual Property - Merck
 
Andrea Marie Perrone
Employment - Merck
Stock and Other Ownership Interests - Merck Sharp & Dohme
Consulting or Advisory Role - Forum Pharmaceuticals (I); Trevi Therapeutics (I); Velicept Therapeutics (I)
Patents, Royalties, Other Intellectual Property - My husband has a patent with UPMC that provides royalties based on predictive models for drug metabolism. (I)
Other Relationship - University of Pennsylvania (I)
 
Geoffrey R. Oxnard
Honoraria - Bio-Rad; Chugai Pharma; Guardant Health; Sysmex
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; DropWorks; Genentech/Roche; GRAIL; Ignyta; Inivata; LOXO; Novartis; Takeda
Patents, Royalties, Other Intellectual Property - DFCI has a patent pending titled "Non-invasive blood-based monitoring of genomic alterations in cancer", on which I am a co-author. (Inst)